Similar articles

• Altered activities of hepatic and extrahepatic microsomal mixed function oxidase enzymes in diabetic and adrenalectomized diabetic rats.

  Al-Turk WA, Stohs SJ, Roche EB. Al-Turk WA, et al. Pharmacology. 1981;23(6):337-45. doi: 10.1159/000137569. Pharmacology. 1981. PMID: 6975948
• Influence of aging and induction of rat liver and kidney microsomal mixed function oxidase systems.

  McMartin DN, O'Connor JA Jr, Fasco MJ, Kaminsky LS. McMartin DN, et al. Toxicol Appl Pharmacol. 1980 Jul;54(3):411-9. doi: 10.1016/0041-008x(80)90168-4. Toxicol Appl Pharmacol. 1980. PMID: 7394797 No abstract available.
• Liver microsomal cytochrome P-450 and related monooxygenase activities in genetically hyperglycemic (ob/ob and db/db) and lean streptozotocin-treated mice.

  Rouer E, Leroux JP. Rouer E, et al. Biochem Pharmacol. 1980 Jul 1;29(13):1959-62. doi: 10.1016/0006-2952(80)90110-0. Biochem Pharmacol. 1980. PMID: 7397002 No abstract available.
• The role of the stimulation of nadph-cytochrome P-450 reductase activity in hepatic, microsomal mixed function oxidase activity.

  Holtzman JL. Holtzman JL. Pharmacol Ther B. 1979;4(3):601-27. doi: 10.1016/0163-7258(79)90006-8. Pharmacol Ther B. 1979. PMID: 224402 Review. No abstract available.
• A reevaluation of the role of cytochrome P-450 as the terminal oxidase in hepatic microsomal mixed function oxidase catalyzed reactions.

  Cooper DY, Schleyer H, Levin SS, Eisenhardt RH, Novack BG, Rosenthal O. Cooper DY, et al. Drug Metab Rev. 1979;10(2):153-85. doi: 10.3109/03602537908997467. Drug Metab Rev. 1979. PMID: 399457 Review. No abstract available.